Since hexokinase serves as the gateway through which glucose enters the alternative metabolic pathway, HK-1 is redundant to the primary catalytic role of HK-2 to ensure the cancer cell a constant glycolytic flux [43]. The gene discussed is HK2; the disease is cancer.